National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody CC49-delta CH2
A humanized CH2 domain-deleted second-generation monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:MOAB HCC49DCH2
MoAb HuCC49DeltaCH2
Monoclonal Antibody HCC49DCH2
Abbreviation:MOAB CC49-deltaCH2



Previous:monoclonal antibody 3H1 anti-idiotype vaccine, monoclonal antibody A27.15, monoclonal antibody A33, monoclonal antibody CAL, monoclonal antibody CC49
Next:monoclonal antibody Ch14.18, monoclonal antibody E2.3, monoclonal antibody G250, monoclonal antibody GD2 anti-idiotype vaccine, monoclonal antibody hA20

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov